The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AAC HLDGS INC | COM | 000307108 | 13,689 | 1,975,347 | SH | SOLE | 1,975,347 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 10,170 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
ADVANCED ACCELERATOR APPLIC | SPONSORED ADS | 00790T100 | 15,339 | 392,904 | SH | SOLE | 392,904 | 0 | 0 | ||
AEGERION PHARMACEUTICALS INC | NOTE 2.000% 8/1 | 00767EAB8 | 13,462 | 16,600,000 | PRN | SOLE | 16,600,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 50,508 | 961,147 | SH | SOLE | 961,147 | 0 | 0 | ||
AETNA INC NEW | COM | 00817Y108 | 19,738 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
AGILE THERAPEUTICS INC | COM | 00847L100 | 3,582 | 955,109 | SH | SOLE | 955,109 | 0 | 0 | ||
AKARI THERAPEUTICS PLC | SPONSORED ADR | 00972G108 | 3,772 | 818,158 | SH | SOLE | 818,158 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259103 | 6,630 | 4,769,551 | SH | SOLE | 4,769,551 | 0 | 0 | ||
ALLSCRIPTS HEALTHCARE SOLUTN | NOTE 1.250% 7/0 | 01988PAD0 | 9,830 | 9,671,000 | PRN | SOLE | 9,671,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 13,230 | 552,859 | SH | SOLE | 552,859 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 14,144 | 75,182 | SH | SOLE | 75,182 | 0 | 0 | ||
ARALEZ PHARMACEUTICALS INC | COM | 03852X100 | 2,220 | 1,644,583 | SH | SOLE | 1,644,583 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 11,627 | 2,279,780 | SH | SOLE | 2,279,780 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 7,030 | 416,729 | SH | SOLE | 416,729 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 10,796 | 509,022 | SH | SOLE | 509,022 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 11,644 | 419,453 | SH | SOLE | 419,453 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 33,081 | 1,729,268 | SH | SOLE | 1,729,268 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 40,320 | 3,655,494 | SH | SOLE | 3,655,494 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 189,636 | 2,308,130 | SH | SOLE | 2,308,130 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 11,297 | 674,428 | SH | SOLE | 674,428 | 0 | 0 | ||
AXOVANT SCIENCES LTD | COM | G0750W104 | 5,547 | 239,180 | SH | SOLE | 239,180 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 19,456 | 3,499,202 | SH | SOLE | 3,499,202 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 2,780 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 5,419 | 216,761 | SH | SOLE | 216,761 | 0 | 0 | ||
BIOSCRIP INC | COM | 09069N108 | 3,605 | 1,327,966 | SH | SOLE | 1,327,966 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 10,286 | 203,000 | SH | SOLE | 203,000 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 9,506 | 119,000 | SH | SOLE | 119,000 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 11,731 | 756,822 | SH | SOLE | 756,822 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 23,754 | 665,197 | SH | SOLE | 665,197 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 18,130 | 247,841 | SH | SOLE | 247,841 | 0 | 0 | ||
EDITAS MEDICINE INC | COM | 28106W103 | 28,684 | 1,709,400 | SH | SOLE | 1,709,400 | 0 | 0 | ||
EHEALTH INC | COM | 28238P109 | 12,979 | 690,348 | SH | SOLE | 690,348 | 0 | 0 | ||
ENDOLOGIX INC | NOTE 3.250%11/0 | 29266SAB2 | 34,309 | 40,500,000 | PRN | SOLE | 40,500,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 10,002 | 662,369 | SH | SOLE | 662,369 | 0 | 0 | ||
ESSA PHARMA INC | COM | 29668H104 | 779 | 1,416,230 | SH | SOLE | 1,416,230 | 0 | 0 | ||
FLUIDIGM CORP DEL | NOTE 2.750% 2/0 | 34385PAA6 | 17,216 | 27,715,000 | PRN | SOLE | 27,715,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 3,793 | 817,435 | SH | SOLE | 817,435 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 14,348 | 187,501 | SH | SOLE | 187,501 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 66,428 | 938,515 | SH | SOLE | 938,515 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 53,085 | 750,000 | SH | Call | SOLE | 750,000 | 0 | 0 | |
GLAUKOS CORP | COM | 377322102 | 37,097 | 894,551 | SH | SOLE | 894,551 | 0 | 0 | ||
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 36,088 | 359,983 | SH | SOLE | 359,983 | 0 | 0 | ||
HORIZON PHARMA INVT LTD | NOTE 2.500% 3/1 | 44052TAB7 | 64,002 | 74,100,000 | PRN | SOLE | 74,100,000 | 0 | 0 | ||
HORIZON PHARMA PLC | SHS | G4617B105 | 106,811 | 8,998,413 | SH | SOLE | 8,998,413 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 45845PAA6 | 21,983 | 22,500,000 | PRN | SOLE | 22,500,000 | 0 | 0 | ||
INTERSECT ENT INC | COM | 46071F103 | 33,249 | 1,189,577 | SH | SOLE | 1,189,577 | 0 | 0 | ||
INVUITY INC | COM NEW | 46187J205 | 8,535 | 1,177,229 | SH | SOLE | 1,177,229 | 0 | 0 | ||
ISIS PHARMACEUTICALS INC DEL | NOTE 1.000%11/1 | 464337AJ3 | 44,891 | 42,200,000 | PRN | SOLE | 42,200,000 | 0 | 0 | ||
JOUNCE THERAPEUTICS INC | COM | 481116101 | 3,478 | 247,872 | SH | SOLE | 247,872 | 0 | 0 | ||
KEMPHARM INC | NOTE 5.500% 2/0 | 488445AB3 | 44,250 | 75,000,000 | PRN | SOLE | 75,000,000 | 0 | 0 | ||
KEMPHARM INC | COM | 488445107 | 2,818 | 704,612 | SH | SOLE | 704,612 | 0 | 0 | ||
LANNET INC | COM | 516012101 | 31,089 | 1,523,957 | SH | SOLE | 1,523,957 | 0 | 0 | ||
LOXO ONCOLOGY INC | COM | 548862101 | 20,141 | 251,167 | SH | SOLE | 251,167 | 0 | 0 | ||
MALLINCKRODT PUB LTD CO | SHS | G5785G107 | 52,813 | 1,178,605 | SH | SOLE | 1,178,605 | 0 | 0 | ||
MANNKIND CORP | COM NEW | 56400P706 | 3,810 | 2,702,403 | SH | SOLE | 2,702,403 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 51,899 | 315,417 | SH | SOLE | 315,417 | 0 | 0 | ||
MOLINA HEALTHCARE INC | COM | 60855R100 | 10,492 | 151,665 | SH | SOLE | 151,665 | 0 | 0 | ||
MYLAN N V | SHS EURO | N59465109 | 53,072 | 1,367,119 | SH | SOLE | 1,367,119 | 0 | 0 | ||
MYOKARDIA INC | COM | 62857M105 | 3,665 | 279,752 | SH | SOLE | 279,752 | 0 | 0 | ||
MYOVANT SCIENCES LTD | COM | G637AM102 | 4,688 | 400,685 | SH | SOLE | 400,685 | 0 | 0 | ||
NEOS THERAPEUTICS INC | COM | 64052L106 | 10,652 | 1,459,195 | SH | SOLE | 1,459,195 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 28,009 | 376,308 | SH | SOLE | 376,308 | 0 | 0 | ||
NEVRO CORP | NOTE 1.750% 6/0 | 64157FAA1 | 29,617 | 27,600,000 | PRN | SOLE | 27,600,000 | 0 | 0 | ||
NIVALIS THERAPEUTICS INC | COM | 65481J109 | 8,995 | 3,732,412 | SH | SOLE | 3,732,412 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 96,102 | 3,833,330 | SH | SOLE | 3,833,330 | 0 | 0 | ||
OBALON THERAPEUTICS INC | COM | 67424L100 | 1,814 | 183,086 | SH | SOLE | 183,086 | 0 | 0 | ||
OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 15,907 | 945,710 | SH | SOLE | 945,710 | 0 | 0 | ||
PATTERSON COMPANIES INC | COM | 703395103 | 18,464 | 393,262 | SH | SOLE | 393,262 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 23,535 | 419,000 | SH | SOLE | 419,000 | 0 | 0 | ||
PROTEON THERAPEUTICS INC | COM | 74371L109 | 1,868 | 1,224,899 | SH | SOLE | 1,224,899 | 0 | 0 | ||
PROTEOSTASIS THERAPEUTICS IN | COM | 74373B109 | 81 | 17,251 | SH | SOLE | 17,251 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 9,090 | 104,000 | SH | Put | SOLE | 104,000 | 0 | 0 | |
RA PHARMACEUTICALS INC | COM | 74933V108 | 1,548 | 82,593 | SH | SOLE | 82,593 | 0 | 0 | ||
RECRO PHARMA INC | COM | 75629F109 | 13,369 | 1,901,685 | SH | SOLE | 1,901,685 | 0 | 0 | ||
SANGAMO THERAPEUTICS INC | COM | 800677106 | 9,630 | 1,094,305 | SH | SOLE | 1,094,305 | 0 | 0 | ||
SELECT MED HLDGS CORP | COM | 81619Q105 | 7,746 | 504,632 | SH | SOLE | 504,632 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 21,052 | 1,060,000 | SH | SOLE | 1,060,000 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM | 82640U107 | 4,090 | 3,495,734 | SH | SOLE | 3,495,734 | 0 | 0 | ||
STEADYMED LTD | SHS | M84920103 | 9,084 | 1,441,913 | SH | SOLE | 1,441,913 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 20,417 | 1,268,945 | SH | SOLE | 1,268,945 | 0 | 0 | ||
TRINITY BIOTECH INVT LTD | NOTE 4.000% 4/0 | 89643QAB4 | 38,430 | 48,000,000 | PRN | SOLE | 48,000,000 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 1,054 | 117,647 | SH | SOLE | 117,647 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 13,891 | 746,841 | SH | SOLE | 746,841 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 11,869 | 562,236 | SH | SOLE | 562,236 | 0 | 0 |